About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Function of Implanted Glucose Sensor 2 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02345967

Function of Implanted Glucose Sensor 2

The purpose of this study is to verify safety and assess tolerance of a long-term, implanted glucose monitoring sensor. The study will also provide data to characterize the response properties and cal...

Lead sponsor: GlySens Incorporated•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

GlySens Incorporated

Collaborators

Profil Institute for Clinical Research, Inc.
AMCR Institute

Age

21 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Either: (1) male or (2) female and not pregnant, breastfeeding, or planning to become pregnant
•Diabetes diagnosis of type 1, or type 2 using insulin
•Under the routine care of a physician for diabetes treatment
•Able to understand and follow directions
•History of compliance with diabetes care regimen
•Able to comply with study requirements regarding planned clinical visits and exams
•In good physical condition without major medical concerns or blood chemistry abnormalities

Exclusion Criteria

•Mental disorders that might affect compliance to protocols
•Diabetes diagnosis type 2 where treatment involves (1) oral medication without insulin or (2) insulin use restricted to a single daily injection of long-acting insulin or (3) control by diet/exercise regimen alone
•History of intolerance or sensitivity to any of the device materials
•History of any adverse reaction or allergy to any of the drugs/agents utilized in the study procedures
•History of recurrent skin infections

Related studies

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Early Tracking of Childhood Health Determinants (ETCHED) Study

NCT03481829 · Diabetes Mellitus, Obesity, and more

RECRUITINGPhase 3

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 13, 2018Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment20

Start dateJan 2015

Last updatedJun 13, 2018

Condition

Diabetes Mellitus

Locations shown

Profil Institute for Clinical Research

Chula Vista, California

AMCR Institute

Escondido, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 13, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions